Performance Nutrition Formulators LLC dba VMI Sports
Letter data
- Company
- Performance Nutrition Formulators LLC dba VMI Sports
- Recipient
- Mr. Thomas M. Reilly, Mr. Frank Fenimore Jr. | President/Partner, CEO/ Partner | Performance Nutrition Formulators LLC dba VMI Sports | 100 Tec Street Unit B | Hicksville | , | NY | 11801 | United States
- Issue date
- 2023-02-09
- Posted date
- Not available
- FDA office
- Center for Food Safety and Applied Nutrition (CFSAN)
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 543959
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Performance Nutrition Formulators LLC dba VMI Sports
MARCS-CMS 543959 —
February 09, 2023
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED
Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. Thomas M. Reilly, Mr. Frank Fenimore Jr.
Recipient Title
President/Partner, CEO/ Partner
Performance Nutrition Formulators LLC dba VMI Sports
100 Tec Street Unit B
Hicksville
,
NY
11801
United States
Issuing Office:
Center for Food Safety and Applied Nutrition (CFSAN)
United States
Dear Mr. Reilly and Mr. Fenimore Jr.:
The Food and Drug Administration has completed evaluation of your firm's corrective actions in response to our Warning Letter CMS# 543959, issued on May 18, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Lillian Aveta
Acting Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1
Content current as of:
02/09/2023
Regulated Product(s)
Dietary Supplements